1
|
Yost JM, Pearson KD, Alexander J, Gilbert E, Hains LA, Barry T, Bencie R, Bowler P, Carter B, Crowe RE, Dean E, Der J, Fisher A, Fisher K, Flores-Renteria L, Guilliams CM, Hatfield C, Hendrickson L, Huggins T, Janeway L, Lay C, Litt A, Markos S, Mazer SJ, McCamish D, McDade L, Mesler M, Mishler B, Nazaire M, Rebman J, Rosengreen L, Rundel PW, Potter D, Sanders A, Seltmann KC, Simpson MG, Wahlert GA, Waselkov K, Williams K, Wilson PS. THE CALIFORNIA PHENOLOGY COLLECTIONS NETWORK: USING DIGITAL IMAGES TO INVESTIGATE PHENOLOGICAL CHANGE IN A BIODIVERSITY HOTSPOT. ACTA ACUST UNITED AC 2020. [DOI: 10.3120/0024-9637-66.4.130] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Jenn M. Yost
- Robert F. Hoover Herbarium, Biological Sciences Department, California Polytechnic State University, San Luis Obispo, CA 93407-0401
| | - Katelin D. Pearson
- Robert F. Hoover Herbarium, Biological Sciences Department, California Polytechnic State University, San Luis Obispo, CA 93407-0401
| | - Jason Alexander
- University and Jepson Herbaria, University of California, Berkeley, CA 94720
| | - Edward Gilbert
- School of Life Sciences, Arizona State University, Tempe, AZ 85287
| | | | - Teri Barry
- UC Davis Center for Plant Diversity, Plant Sciences M.S. 7, One Shields Ave., Davis, CA 95616
| | - Robin Bencie
- Vascular Plant Herbarium, Humboldt State University, Arcata, CA 95521
| | - Peter Bowler
- UCI Arboretum and Herbarium, University of California, Irvine, CA 92697
| | - Benjamin Carter
- Carl W. Sharsmith Herbarium and Department of Biological Sciences, San Jose State University, San Jose, CA 95192
| | - Rebecca E. Crowe
- UCI Arboretum and Herbarium, University of California, Irvine, CA 92697
| | - Ellen Dean
- UC Davis Center for Plant Diversity, Plant Sciences M.S. 7, One Shields Ave., Davis, CA 95616
| | - Joshua Der
- Department of Biological Science, California State University, Fullerton, CA 92834
| | - Amanda Fisher
- Department of Biological Sciences, Long Beach State University, Long Beach, CA 90840
| | - Kirsten Fisher
- CSLA Herbarium, California State University, Los Angeles, Los Angeles, CA 90032
| | | | - C. Matt Guilliams
- Clifton Smith Herbarium, Santa Barbara Botanic Garden, Santa Barbara, CA 93105
| | - Colleen Hatfield
- Chico State Herbarium, Department of Biological Sciences, California State University, Chico, CA 95929
| | - Larry Hendrickson
- Colorado Desert District, California Department of Parks and Recreation, Borrego Springs, CA 92004
| | - Tom Huggins
- UCLA Herbarium, University of California, Los Angeles, CA 90095
| | - Lawrence Janeway
- Chico State Herbarium, Department of Biological Sciences, California State University, Chico, CA 95929
| | - Christopher Lay
- Norris Center for Natural History, University of California, Santa Cruz, CA 95064
| | - Amy Litt
- Department of Botany & Plant Sciences, University of California, Riverside, CA 92521
| | - Staci Markos
- University and Jepson Herbaria, University of California, Berkeley, CA 94720
| | - Susan J. Mazer
- Department of Ecology, Evolution and Marine Biology, University of California, Santa Barbara, CA 93106
| | - Danny McCamish
- Colorado Desert District, California Department of Parks and Recreation, Borrego Springs, CA 92004
| | | | - Michael Mesler
- Vascular Plant Herbarium, Humboldt State University, Arcata, CA 95521
| | - Brent Mishler
- University and Jepson Herbaria, University of California, Berkeley, CA 94720
| | - Mare Nazaire
- Rancho Santa Ana Botanic Garden, Claremont, CA 91711
| | - Jon Rebman
- SD Herbarium, San Diego Natural History Museum, San Diego, CA 92101
| | - Lars Rosengreen
- Carl W. Sharsmith Herbarium and Department of Biological Sciences, San Jose State University, San Jose, CA 95192
| | - Philip W. Rundel
- Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA 90095
| | - Dan Potter
- Department of Plant Sciences, University of California, Davis, CA 95616
| | - Andrew Sanders
- Herbarium, Department of Botany & Plant Sciences, University of California Riverside, CA 92521
| | - Katja C. Seltmann
- Cheadle Center for Biodiversity and Ecological Restoration, University of California, Santa Barbara, CA 93106
| | | | - Gregory A. Wahlert
- Cheadle Center for Biodiversity and Ecological Restoration, University of California, Santa Barbara, CA 93106
| | | | - Kimberlyn Williams
- Biology Department, California State University San Bernardino, San Bernardino, CA 92407
| | - Paul S. Wilson
- Department of Biology, California State University, Northridge, CA 91330
| |
Collapse
|
2
|
Higginson M, Palmer K, King J, Dawkins B, Huggins T, Ingman L, Taylor F, Xu N, Kaye P. Development of automated separations for actinides analysis. J Radioanal Nucl Chem 2019. [DOI: 10.1007/s10967-019-06542-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Cannon M, Khambe D, Klukowska M, Ramsey DL, Miner M, Huggins T, White DJ. Clinical Effects of Stabilized Stannous Fluoride Dentifrice in Reducing Plaque Microbial Virulence II: Metabonomic Changes. J Clin Dent 2018; 29:1-12. [PMID: 29758151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
OBJECTIVES The clinical effects of stannous fluoride (SnF2) dentifrice in reducing symptoms of gingivitis and reducing the virulence of subgingival plaque through suppression of activation of gene expression in toll receptor based reporter cells were previously reported. This study expanded analysis of the clinical study to include evaluation of dentifrice effects on salivary metabolites using 1H Nuclear Magnetic Resonance (1H NMR) systems biology-based metabonomics. METHODS The clinical design was reported previously (J Clin Dent2017;28:16-26). Participants included a cohort exhibiting high and low levels of gingival disease as presented at initiation of the study. Participants provided morning lavage saliva samples at baseline. Following this, participants were provided with a hygiene intervention, including a stabilized SnF2 dentifrice and a new soft bristle manual toothbrush. Following two and four weeks of assigned dentifrice use, participants again collected morning lavage saliva samples. Samples were analyzed by 1HNMR spectroscopy on a Bruker 600MHz NMR spectrometer. System-wide analyses were carried out by partial least squared (PLS) comparisons of aggregate spectra, and discrete metabolites with established spectral signatures were likewise directly compared. RESULTS PLS analysis showed significant differences in saliva composition for saliva collected from high bleeding and low bleeding cohorts. Clear shifts in saliva composition were observed in system-wide PLS analysis following intervention of SnF2 dentifrice for both cohorts. A number of discrete spectral changes were consistently observed with SnF2 dentifrice intervention, most notably including reductions in propionic acid and butyric acid, key short chain fatty acids associated with anaerobic metabolism in dental plaques. CONCLUSIONS These results collectively demonstrate that SnF2 dentifrice treatment was associated with broad scale modifications in saliva composition following intervention in both high and low diseased cohorts. Changes in overall salivary composition and specific reductions in saliva concentrations of propionic and butyric acid reductions occurred coincident with clinical improvements in gingivitis and gingival bleeding. These results provide support for the hypothesis that the effectiveness of SnF2 dentifrice in improving gingival health is associated with a modification of microbiome metabolism, including suppression of short chain fatty acid metabolites.
Collapse
|
4
|
Klukowska M, Haught JC, Xie S, Circello B, Tansky CS, Khambe D, Huggins T, White DJ. Clinical Effects of Stabilized Stannous Fluoride Dentifrice in Reducing Plaque Microbial Virulence I: Microbiological and Receptor Cell Findings. J Clin Dent 2017; 28:16-26. [PMID: 28657701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVES Lipopolysaccharides (LPSs) and lipoteichoic acids (LTAs), or bacterial endotoxins, bind with Toll-like receptors (TLRs) that are expressed on host cells of the periodontium, thereby contributing to the periodontal pathogenicity of oral bacteria. Stannous fluoride (SnF2), an antibacterial fluoride that treats and controls gingivitis, has been shown to react with lipophilic domains/anionic charges in LPS and LTA. The effects of bacterial species and dental plaque on toll receptors can be studied using genetically engineered cell lines containing linked toll receptors on their surfaces. This randomized, examiner-blinded study examined the clinical effects of stabilized SnF2 dentifrice intervention on gingivitis and dental plaque virulence in populations exhibiting high and low levels of clinical gingivitis. METHODS Recruited populations were evaluated for gingival inflammation (MGI) and gingival bleeding (GBI) at baseline and assigned into two cohorts of 20 each, those with high (GBI > 20 sites) and low (GBI < 3 sites) levels of observed bleeding/gingivitis. Participants were sampled at baseline for both supra- and subgingival dental plaque at both healthy (no bleeding, PD = 2 mm), as well as clinically diseased sites (bleeding, PD = 3-4 mm), and then provided with an intervention hygiene product including a stabilized SnF2 dentifrice and a new soft bristle manual toothbrush. Following two and four weeks of assigned dentifrice use, participants returned for a re-evaluation of gingival inflammation and bleeding and repeat samplings of dental plaque. Plaque samples were analyzed by anaerobic culturing of gram negative anaerobes (GNA), as well as by incubation of subgingival sampled plaques with TLR4 transfected HEK293 cells, where gene expression was assessed by measurement of a SEAP alkaline phosphatase reporter as a marker of toll receptor activation. RESULTS Clinical assessments showed statistically significant reductions in MGI (24-26%) and GBI (42-53%) gingivitis in both diseased and healthy cohorts following four weeks of dentifrice intervention. For all clinical examinations, MGI and bleeding sites were statistically significantly different (lower) in the low bleeding versus the higher bleeding cohort. Supragingival and subgingival GNAs were significantly reduced (p < 0.05) in both high and low disease cohorts at bleeding and healthy sites following four weeks of stabilized SnF2 dentifrice use. TLR activation from subgingival sampled plaque was reduced following four weeks of stabilized SnF2 dentifrice use in both high and low disease cohorts and in both healthy, as well as diseased sites. CONCLUSIONS Collectively, these results support the potential for stabilized SnF2 dentifrice to provide clinical gingivitis benefits via mechanisms beyond control of plaque mass, potentially directly decreasing the pathogenicity of plaque biofilms by blocking reactivity of LPS and LTA ligands with tissue receptors associated with inflammation. Importantly, benefits could be seen in both diseased sites, as well as sites not yet exhibiting symptoms of inflammation, supporting the activity of SnF2 not just in treating diseased sites, but in preventing disease development. These learnings may influence treatment planning for patients susceptible to gingivitis.
Collapse
Affiliation(s)
| | | | - Sancai Xie
- The Procter & Gamble Company, Mason, OH, USA
| | | | | | | | - Tom Huggins
- The Procter & Gamble Company, Mason, OH, USA
| | | |
Collapse
|
5
|
Haught JC, Xie S, Circello B, Tansky CS, Khambe D, Sun Y, Lin Y, Sreekrishna K, Klukowska M, Huggins T, White DJ. Lipopolysaccharide and lipoteichoic acid binding by antimicrobials used in oral care formulations. Am J Dent 2016; 29:328-332. [PMID: 29178720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
PURPOSE To study the reactivity of lipopolysaccharide (LPS) and lipoteichoic acid (LTA) with the cationically charged agents cetylpyridinium chloride, stannous fluoride, and the non-cationic agent triclosan. We also assessed the effect of these agents to inhibit LPS and LTA binding to cellular Toll-like Receptors (TLRs) in vitro. METHODS The ability of these antimicrobials to bind with LPS and/or LTA was assessed in both the Limulus amebocyte lysate and BODIPY-TR-cadaverine dye assays. Mass spectroscopy was then used to confirm that stannous fluoride directly binds with LPS and to determine stoichiometry. Lastly, we looked for possible inhibitory effects of these antimicrobial agents on the ability of fluorescently conjugated LPS to bind to TLR4 expressed on HEK 293 cells. RESULTS Cetylpyridinium chloride (CPC) and stannous salts including stannous fluoride interfered with LPS and LTA reactivity in both dye assays, while triclosan had no effect. Mass spectroscopy revealed direct binding of stannous fluoride with E. Coli LPS at 1:1 stoichiometric ratios. In the cellular assay, cetylpyridinium chloride and stannous fluoride, but not triclosan, inhibited LPS binding to TLR4. CLINICAL SIGNIFICANCE These results support a potential mechanism of action for stannous fluoride and CPC formulated in oral products in which these ingredients bind bacterial toxins and potentially render them less toxic to the host. These results may influence home care recommendations for patients at risk for plaque-related diseases.
Collapse
Affiliation(s)
| | - Sancai Xie
- The Procter $ Gamble Company, Mason, Ohio, USA
| | | | | | | | - Yiping Sun
- The Procter $ Gamble Company, Mason, Ohio, USA
| | - Yakang Lin
- The Procter $ Gamble Company, Mason, Ohio, USA
| | | | | | - Tom Huggins
- The Procter $ Gamble Company, Mason, Ohio, USA
| | | |
Collapse
|
6
|
Huggins T, Haught JC, Xie S, Tansky CS, Klukowska M, Miner MC, White DJ. Quantitation of endotoxin and lipoteichoic acid virulence using toll receptor reporter gene. Am J Dent 2016; 29:321-327. [PMID: 29178719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
PURPOSE To apply quantitative Toll-like receptors (TLR) cell assays to compare lipopolysaccharides (LPSs) and lipoteichoic acids (LTAs) from different oral bacterial strains for potential pathogenicity in vitro. METHODS The potency of LPS and LTA from different bacteria on activation of TLR reporter genes in HEK-tlr cell lines was examined. P. gingivalis LPS mix, P. gingivalis 1690 LPS, P. gingivalis 1435/50 LPS, E. coli LPS (E. coli K12), B. subtilis LTA, S. aureus LTA, E. hirae LTA and S. pyogenes LTA were examined in both TLR2 and TLR4 HEK cell line reporter assays. Solutions of LPS and LTA from selected bacteria were applied in a dose response fashion to the TLR reporter cells under standard culture conditions for mammalian cells. Reporter gene secreted-embryonic-alkaline-phosphatase (SEAP) was measured, and half maximal effective concentration (EC50) was determined for each sample. Concentration dependent TLR activation was compared to similar responses to LPS and LTA for commercial BODIPY-TR-Cadaverine and LAL biochemical (non cell based) assays. RESULTS All LPS from P. gingivalis activated both TLR2 and TLR4 responses. E. coli LPS is a strong activator for TLR4 but not for TLR2 responses. In contrast, both B. subtilis and S. aureus LTA provoked responses only in TLR2, but not in the TLR4 assay. Interestingly, E. hirae LTA and S. pyogenes LTA did not stimulate strong TLR2 responses. Instead, both E. hirae LTA and S. pyogenes LTA mounted a reasonable response in TLR4 reporter gene assay. Both LPS and LTA showed deactivation of fluorescence in BODIPY-TR-Cadaverine while only LPS was active in LAL. As with biochemical assays, an EC50 could be determined for LPS and LTA from various bacterial strains. The EC50 is defined as a concentration of LPS or LTA that provokes a response halfway between the baseline and maximum responses. Lower EC50 means higher potency in promoting TLR responses, and in principle indicates greater toxicity to the host. CLINICAL SIGNIFICANCE InvivoGen TLR2 and TLR4 assays distinguish specific types of microbial products, such as LPS and LTA from different bacteria. Application of EC50 determinations creates a means for quantitative and comparisons of LPS and LTA virulence in a cellular-based assay and combinations of TLR reporter cell assays along with biochemical evaluation of LPS#47;LTA in BODIPY-TR-Cadaverine and LPS in LAL assays provides a means to quantitate virulence of plaque samples with respect to both LPS and LTA. These learnings have long-term implications for patient care in that understanding the virulence of patients' plaque provides important information to assess risk of oral diseases.
Collapse
Affiliation(s)
- Tom Huggins
- The Procter $ Gamble Company, Mason, Ohio, USA
| | | | - Sancai Xie
- The Procter $ Gamble Company, Mason, Ohio, USA
| | | | | | | | | |
Collapse
|
7
|
Haught C, Xie S, Circello B, Tansky CS, Khambe D, Klukowska M, Huggins T, White DJ. Lipopolysaccharide and Lipoteichoic Acid Virulence Deactivation by Stannous Fluoride. J Clin Dent 2016; 27:84-89. [PMID: 28390203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVES Oral bacterial pathogens promote gingivitis and periodontal disease. Bacterial endotoxins, also known as lipopolysaccharides (LPSs) and lipoteichoic acids (LTAs), are known to enhance bacterial pathogenicity through binding with Toll-like receptors (TLRs), a group of pattern recognition receptors critical to the activation of innate immunity, that are expressed on host cells. Both LPS and LTA contain lipophilic domains and anionic charges that may be susceptible to reactivity with stannous fluoride, a commonly used ingredient clinically proven for the treatment and prevention of gingivitis. This study examined the effects of stannous fluoride on Toll-like receptor activation in response to bacterially derived LPS and LTA in select cell lines and secretion of inflammatory cytokines from human primary peripheral monocytes likewise exposed to LPS. METHODS TLR4 and TLR2 transfected HEK293 cells and THP1-Dual™ cells were exposed to bacterial LPS and LTA in the presence of increasing concentrations of stannous fluoride. Gene expression was assessed by measurement of secreted embryonic alkaline phosphatase (SEAP) reporter gene for HEK293 cells and SEAP and luciferase for THP-1 cells. Cell viability was confirmed using PrestoBlue. Human primary monocytes were treated with LPS with various concentrations of supplemented stannous fluoride, and cytokine expression was directly measured. RESULTS Stannous fluoride inhibited gene expression response of TLR4 and TLR2 in HEK293 cells and THP1-Dual™ cells in a dose response fashion, producing complete inhibition at micromolar concentrations. The addition of stannous fluoride suppressed production of TNF-a, IFN-g, IL12p70, IL10, IL-1b, IL2, and IL-6, and also increased secretion of Il-8 in dose response fashion. Viability assays confirmed no effects of LPS or stannous fluoride on viability of HEK293, THP-1, and primary human monocytes. CONCLUSIONS These results support the potential for stannous fluoride to provide clinical gingivitis benefits by directly decreasing the pathogenicity of plaque biofilms by blocking reactivity of LPS and LTA ligands with tissue receptors associated with inflammation. These learnings may influence recommendations for patients at risk for plaque-related diseases.
Collapse
Affiliation(s)
| | - Sancai Xie
- The Procter & Gamble Company, Mason, OH, USA
| | | | | | | | | | - Tom Huggins
- The Procter & Gamble Company, Mason, OH, USA
| | | |
Collapse
|
8
|
Winget JM, Finlay D, Mills KJ, Huggins T, Bascom C, Isfort RJ, Moritz RL. Quantitative Proteomic Analysis of Stratum Corneum Dysfunction in Adult Chronic Atopic Dermatitis. J Invest Dermatol 2016; 136:1732-1735. [PMID: 27091361 DOI: 10.1016/j.jid.2016.03.037] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Revised: 03/16/2016] [Accepted: 03/25/2016] [Indexed: 10/22/2022]
Affiliation(s)
| | | | | | - Tom Huggins
- The Procter & Gamble Company, Cincinnati, Ohio, USA
| | | | | | | |
Collapse
|
9
|
Klukowska M, Goyal CR, Khambe D, Cannon M, Miner M, Gurich N, Circello B, Huggins T, Barker ML, Furnish C, Conde E, Hoke P, Haught C, Xie S, White DJ. Response of chronic gingivitis to hygiene therapy and experimental gingivitis. Clinical, microbiological and metabonomic changes. Am J Dent 2015; 28:273-284. [PMID: 26714345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
PURPOSE To compare the clinical, microbiological and metabonomic profiles of subjects with high and low levels of chronic gingival bleeding during a controlled oral hygiene regimen intervention including sequential phases of rigorous therapeutic oral hygiene followed by experimental gingivitis (EG). METHODS Two cohorts of qualified study subjects with differences in gingival bleeding on probing levels at their baseline clinical examination were entered into the study. These two cohorts were followed through three separate study phases including a 1-week baseline phase, a 2-week phase of rigorous oral hygiene including dental prophylaxis, and a 3-week EG phase of no oral hygiene to encourage relapse of gingivitis. The 58 subjects were assessed during each phase of the study for clinical presentation of gingivitis and concurrently had plaque sampled for real-time polymerase chain reaction (RTPCR) microbiological characterization and salivary lavage samples for 'systems biology' metabonomics assessment by 1H-NMR. RESULTS Subjects presenting with different levels of gingival bleeding on probing when they entered the study responded differently to rigorous oral hygiene and EG. Specifically, the high bleeding cohort responded sluggishly to rigorous oral hygiene and exhibited markedly greater relapse to gingivitis during EG. RTPCR analysis showed changes in bacterial populations that were associated with study phases, particularly the increases in putative periodontal pathogens during EG. However, the microbiological profiles of high- and low-susceptibility gingival bleeding patients were largely similar. Metabonomic analysis likewise revealed significant changes in metabolite composition during study phases associated with differences in plaque toxicity, especially the short chain carboxylic acids propionate and n-butyrate, which tracked clinical changes in gingivitis severity. Systems analysis of metabonomic changes suggested differences between cohorts, although analysis to date has not elucidated whether these differences are causative (population predictive) or simply diagnostic of clinical status within populations.
Collapse
|
10
|
Winget JM, Watts JD, Hoopmann MR, DiColandrea T, Robinson MK, Huggins T, Bascom CC, Isfort RJ, Moritz RL. Quantitative proteogenomic profiling of epidermal barrier formation in vitro. J Dermatol Sci 2015; 78:173-80. [PMID: 25862149 DOI: 10.1016/j.jdermsci.2015.02.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2015] [Revised: 02/13/2015] [Accepted: 02/24/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND The barrier function of the epidermis is integral to personal well-being, and defects in the skin barrier are associated with several widespread diseases. Currently there is a limited understanding of system-level proteomic changes during epidermal stratification and barrier establishment. OBJECTIVE Here we report the quantitative proteogenomic profile of an in vitro reconstituted epidermis at three time points of development in order to characterize protein changes during stratification. METHODS The proteome was measured using data-dependent "shotgun" mass spectrometry and quantified with statistically validated label-free proteomic methods for 20 replicates at each of three time points during the course of epidermal development. RESULTS Over 3600 proteins were identified in the reconstituted epidermis, with more than 1200 of these changing in abundance over the time course. We also collected and discuss matched transcriptomic data for the three time points, allowing alignment of this new dataset with previously published characterization of the reconstituted epidermis system. CONCLUSION These results represent the most comprehensive epidermal-specific proteome to date, and therefore reveal several aspects of barrier formation and skin composition. The limited correlation between transcript and protein abundance underscores the importance of proteomic analysis in developing a full understanding of epidermal maturation.
Collapse
Affiliation(s)
- Jason M Winget
- Institute for Systems Biology, 401 Terry Ave N., Seattle, WA 98109, USA
| | - Julian D Watts
- Institute for Systems Biology, 401 Terry Ave N., Seattle, WA 98109, USA
| | | | - Teresa DiColandrea
- The Procter & Gamble Company, Mason Business Center, Cincinnati, OH 45040, USA
| | - Michael K Robinson
- The Procter & Gamble Company, Mason Business Center, Cincinnati, OH 45040, USA
| | - Tom Huggins
- The Procter & Gamble Company, Mason Business Center, Cincinnati, OH 45040, USA
| | - Charles C Bascom
- The Procter & Gamble Company, Mason Business Center, Cincinnati, OH 45040, USA
| | - Robert J Isfort
- The Procter & Gamble Company, Mason Business Center, Cincinnati, OH 45040, USA
| | - Robert L Moritz
- Institute for Systems Biology, 401 Terry Ave N., Seattle, WA 98109, USA.
| |
Collapse
|
11
|
Osuch EA, Cora-Locatelli G, Frye MA, Huggins T, Kimbrell TA, Ketter TA, Callahan AM, Post RM. Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. Acta Psychiatr Scand 2001; 104:397-401. [PMID: 11722323 DOI: 10.1034/j.1600-0447.2001.00395.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE Previous studies show a state-dependent relationship between depression and post-dexamethasone suppression test (DST) cortisol level, as well as differences in DST response with age and gender. METHOD In this study, 74 research in-patients with affective disorders were given the DST on placebo and in a subgroup following treatment with carbamazepine. Depression was evaluated twice daily with the Bunney-Hamburg (BH) rating scale. Data were examined for the total subject population, by gender and by menopausal status in women. RESULTS A robust positive correlation was observed between depression severity and post-DST cortisol in pre- and postmenopausal females, but not in males. This relationship persisted in women when restudied on a stable dose of carbamazepine (n=42). CONCLUSION The pathophysiological implications of this selective positive relationship between severity of depression and post-DST cortisol in women, but not men, should be explored further.
Collapse
Affiliation(s)
- E A Osuch
- Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Little JT, Kimbrell TA, Wassermann EM, Grafman J, Figueras S, Dunn RT, Danielson A, Repella J, Huggins T, George MS, Post RM. Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13:119-24. [PMID: 10780630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
OBJECTIVE To determine the cognitive effects of daily repetitive transcranial magnetic stimulation (rTMS) administered under the conditions of a treatment trial for major depression. BACKGROUND Although daily left dorsal prefrontal rTMS has improved mood in some patients with treatment-refractory depression, potential cognitive side effects of extended daily treatment have not been systematically studied. METHOD In a randomized double-blind treatment study, 10 subjects (mean age, 42 +/- 15 years) with an episode of major depression received either 2 weeks of low-frequency (1 Hz) or high-frequency (20 Hz) rTMS (800 pulses, 20 trains over 20 minutes, 80% of motor threshold, 5 days per week) to the left dorsolateral prefrontal cortex and then were crossed over to the other treatment condition. Patients received cognitive testing at baseline and after the first and second weeks of low- or high-frequency rTMS, which was examined by repeated-measures ANOVA. RESULTS Of 16 cognitive measures tested after 1 or 2 weeks of rTMS compared with baseline status, none showed deterioration, and the only significant main treatment effect indicated improvement on a list-recall test from pre- to post-rTMS after 1 week (p <0.05). CONCLUSIONS These preliminary data suggest no gross deleterious cognitive effects of 2 weeks of 1- or 20-Hz rTMS at 80% of motor threshold over the left prefrontal cortex. Further cognitive studies of the effects of rTMS at other parameters used in clinical trials for mood disorders remain to be undertaken.
Collapse
Affiliation(s)
- J T Little
- Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892-1272, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61:9-15. [PMID: 10695639 DOI: 10.4088/jcp.v61n0104] [Citation(s) in RCA: 209] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
BACKGROUND Few studies have approached the subject of polypharmacotherapy systematically. This retrospective review of 178 patients with refractory bipolar disorder or unipolar depression (Research Diagnostic Criteria or DSM-III-R criteria) discharged from the National Institute of Mental Health (NIMH) Biological Psychiatry Branch between 1974 and 1996 was conducted to assess the degree and efficacy of "add-on" pharmacotherapy. METHOD Following completion of formal structured blinded research protocols, patients entered a treatment phase (often again on a blind basis) in which all agents available in the community could be utilized. Each patient's retrospective life chart and all prospective double-blind nurse- and self-rated NIMH data were reviewed. The overall degree of improvement at discharge was assessed by rating on the Clinical Global Impressions scale (CGI) as modified for bipolar illness (CGI-BP). RESULTS A 78% improvement rate (moderate or marked on the CGI) was achieved at the time of discharge. There was a significant relationship between number of medications utilized at discharge as a function of discharge date (r = 0.45, p < .0001). The percentages of patients discharged on treatment with 3 or more medications were 3.3% (1974-1979), 9.3% (1980-1984), 34.9% (1985-1989), and 43.8% (1990-1995). No correlation was found between polypharmacy and age (r = -0.03, p = .66). Patients more recently discharged from the NIMH had an earlier age at illness onset, more lifetime weeks depressed, and a higher rate of rapid cycling than patients in the earlier cohorts. CONCLUSION Increasing numbers of medications in more recent NIMH cohorts were required to achieve the same degree of improvement at hospital discharge. More systematic approaches to the complex regimens required for treatment of patients with refractory mood disorder are clearly needed.
Collapse
Affiliation(s)
- M A Frye
- Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1272, USA
| | | | | | | | | | | | | |
Collapse
|
14
|
Frye MA, Gary KA, Marangell LB, George MS, Callahan AM, Little JT, Huggins T, Corá-Locatelli G, Osuch EA, Winokur A, Post RM. CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression. J Neuropsychiatry Clin Neurosci 1999; 11:349-53. [PMID: 10440011 DOI: 10.1176/jnp.11.3.349] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In light of the postulated role of thyrotropin-releasing hormone (TRH) as an endogenous anti-depressant, 56 refractory mood-disordered patients and 34 healthy adult control subjects underwent lumbar puncture for cerebrospinal fluid (CSF) TRH analysis. By two-way analysis of variance, there was no difference between CSF TRH in patients (as a group or by diagnostic subtype) and control subjects (n = 90, F = 0.91, df = 2.84, P = 0.41). There was, however, a CSF TRH gender difference (females, 2.95 pg/ml; males, 3.98 pg/ml; n = 90, F = 4.11, df = 1.84, P < 0.05). A post hoc t-test revealed the greatest gender difference in the bipolar group (t = 2.52, P < 0.02). There was no significant difference in CSF TRH in "ill" vs. "well" state (n = 20, P = 0.41). The role of elevated levels of CSF TRH in affectively ill men--or the role of decreased levels of CSF TRH in affectively ill women--remains to be investigated but could be of pathophysiological relevance.
Collapse
Affiliation(s)
- M A Frye
- Biological Psychiatry Branch, National Institute of Mental Health (NIMH), Bethesda, Maryland, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
George MS, Huggins T, McDermut W, Parekh PI, Rubinow D, Post RM. Abnormal facial emotion recognition in depression: serial testing in an ultra-rapid-cycling patient. Behav Modif 1998; 22:192-204. [PMID: 9563292 DOI: 10.1177/01454455980222007] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Normal subjects use the right insula and bilateral anterior temporal and prefrontal cortices to recognize the emotion expressed in a human face. Mood disorder subjects have a selective deficit in recognizing human facial emotion. Brain imaging studies show that they fail to activate the right insula to the same degree as controls, even when accurately assessing facial emotion. Many issues remain, however, including whether the facial emotion recognition errors in mood disorder subjects are state dependent or persist during normal mood states (and, thus, reflect a trait abnormality). To probe this issue, we repeatedly studied a male bipolar II patient's ability to recognize faces' emotional content. This patient made significantly more errors in facial emotion recognition during the depressed state. He also demonstrated a significant negative bias when he was depressed compared with nondepressed states. This case study demonstrates the state dependency of the defect in human facial emotion recognition.
Collapse
Affiliation(s)
- M S George
- Department of Radiology, Medical University of South Carolina, Charleston 29425, USA.
| | | | | | | | | | | |
Collapse
|
16
|
Abstract
Thyroid indices were measured after an extended period of medication-free evaluation averaging 6 weeks in 67 consecutively admitted patients with bipolar illness. Thyroid hormone levels -- thyroxine (T4), free T4 and triiodothyronine (T3) -- were not significantly different in the 31 rapid cyclers (> or = 4 affective episodes/year) than in 36 non-rapid cyclers. Analysis of covariance indicated a non-significant trend relation between higher T4 and a greater number of affective episodes in the year prior to admission and male gender when age was covaried. Several previous reports, primarily in medicated subjects, have suggested a link between rapid cycling patients and decreased peripheral thyroid indices (low hormone levels and elevated TSH), but now the majority of studies do not support such a relation. Among those in the literature, this study includes patients studied for the longest time off medications and further suggests that the commonly-cited relation between subclinical hypothyroidism and rapid cycling bipolar illness be reevaluated.
Collapse
Affiliation(s)
- R M Post
- Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892, USA
| | | | | | | | | | | | | |
Collapse
|
17
|
Marangell LB, George MS, Bissette G, Pazzaglia P, Huggins T, Post RM. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients. Arch Gen Psychiatry 1994; 51:625-8. [PMID: 8042911 DOI: 10.1001/archpsyc.1994.03950080037005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
BACKGROUND Thyrotropin-releasing hormone is an endogenous tripeptide with endocrine-independent neurophysiologic properties that may be relevant to affective or seizure disorders. We studied the effect of carbamazepine, which has both mood-stabilizing and anticonvulsant properties, on cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients. METHOD Paired cerebrospinal fluid samples were collected from nine inpatients with mood disorders, both while medication free and while taking carbamazepine for an average of longer than 1 month at 950 mg/d, achieving blood levels of 8.8 mg/L. RESULTS Carbamazepine treatment was consistently and significantly associated with increased cerebrospinal fluid thyrotropin-releasing hormone levels (P < .0001). CONCLUSION As carbamazepine-induced increases in thyrotropin-releasing hormone levels could be relevant to either its psychotropic or anticonvulsant properties, further clinical and preclinical investigation of this finding appears indicated.
Collapse
Affiliation(s)
- L B Marangell
- Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Md
| | | | | | | | | | | |
Collapse
|
18
|
Post RM, Uhde TW, Rubinow DR, Huggins T. Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications. Psychiatry Res 1987; 22:11-9. [PMID: 3659217 DOI: 10.1016/0165-1781(87)90045-x] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The pattern and time course of antidepressant response to different treatment modalities provide important clinical information and hints about underlying neurobiological mechanisms. Depressed patients who responded to 1 night's sleep deprivation (11 of 33 patients) showed maximal improvement on day 1 and deterioration in mood thereafter. In contrast, slower onset and more sustained effects were observed following carbamazepine (12 of 37) or electroconvulsive therapy (ECT) (8 of 8). Nearly maximal improvement required about 2 weeks for ECT and 3 weeks for carbamazepine. Possible differential or common biological mechanisms with differential times of action are implied by these data, which are of importance to the neuroscientist attempting to uncover neural substrates of antidepressant response and the clinician attempting to find rapid onset, yet sustained antidepressant treatments.
Collapse
Affiliation(s)
- R M Post
- Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892
| | | | | | | |
Collapse
|